Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 1, 2022 | LifeMine Therapeutics | $180.0M Series C | Fidelity Management & Research Company | ARCH Venture Partners, Foresite Capital, F-Prime Capital Partners, GV, Mubadala, Blue Pool Capital, GlaxoSmithKline, Invus, MRL Ventures Fund |
| Oct 20, 2021 | Steadiwear | $890K Seed | 3W Partners | Centre for Aging + Brain Health Innovation, Ontario Brain Institute |
| May 9, 2018 | CStone Pharmaceuticals | $259.2M Series B | GIC | 6 Dimensions Capital, ARCH Venture Partners, AVICT Global, Boyu Capital, CPE, Hillhouse Capital, Hongshan Capital Group (Sequoia Capital China), King Star Capital, Taikang, Terra Magnum Capital Partners, WuXi Healthcare Ventures, Yunfeng Capital |
| Sep 7, 2017 | NextCODE Health | $240.0M Series B | Sequoia Capital | Amgen Ventures, Temasek, Jack Ma |
| Jun 14, 2017 | Twist Bioscience | $27.0M Other Equity | — | Bay City Capital, Biomatics Capital, Ditch Plains Capital Management, FIS, GF Xinde Life Science Investment Fund, KANGMEI Group, NFT Investment Limited, Reinet Investments |